Clinical Trial Update: A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 trial updates on safety and efficacy of JNS024 ER for chronic malignant tumor-related cancer pain in Japanese and Korean patients, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• JNS024 ER

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2014-01-15